The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme
- PMID: 14616426
- PMCID: PMC1884300
- DOI: 10.1046/j.1365-2125.2003.01903.x
The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme
Abstract
Aims: In order to aid the monitoring of the new Meningococcal serogroup C Conjugate (Men C) vaccine, the Yellow Card Scheme was extended to allow nurses for the first time to report any suspected adverse reactions associated with these vaccines. We have analysed the Yellow Cards received by the Committee on Safety of Medicines (CSM) Wales from nurses reporting a suspected reaction in association with these vaccines during the first 16 months of the programme.
Methods: CSM Wales receives Yellow Cards from healthcare professionals in Wales. Details of Yellow Cards reporting a suspected adverse reaction associated with Men C vaccines during the study period were extracted from the CSM Wales database and analysed according to health professional category [nurses, General Practitioners (GP), hospital doctors or pharmacists].
Results: During the study period 534 117 doses of Men C vaccines were administered in Wales; in the same period CSM Wales received 1095 Yellow Cards containing 1952 suspected reactions. Nurses completed 529 [48.3%, 95% confidence interval (CI) 43.6, 53.1] Yellow Cards compared with 294 (26.8%, 95% CI 22.7, 30.8) from GPs, 262 (23.9%, 95% CI 20.1, 27.6) from hospital doctors and 10 (0.91%, 95% CI 0.43, 1.73) from others, which include hospital pharmacists, community pharmacists and health visitors. The proportion of Yellow Cards sent by nurses was significantly higher than those sent by GPs and hospital doctors. Ninety-five percent CIs for differences in proportions (CI diff prop) were (0.175, 0.254) and (0.204, 0.282), respectively. The majority (90.9%, 95% CI 88.7, 93.5) of the Yellow Cards from nurses reported suspected reactions children in over the age of 5 (95% CI diff prop 0.861, 0.917). The spectrum of suspected adverse drug reactions (ADRs) involved the skin and subcutaneous tissue, central nervous system, general reactions, and the gastrointestinal tract. Of the suspected reactions reported by nurses, GPs and hospital doctors, 13.4% (95% CI 10.5, 15.8), 12.9% (95% CI 9.6, 16.8) and 9.1% (95% CI 6.5, 11.8), respectively, were of serious reactions. Nurses reported 52.5% (95% CI 45.4, 60.6) of all the suspected serious reactions, which was statistically more significant than hospital doctors [chi2 = 5.864, degree of freedom (DF) = 1, P < 0.05] but not GPs (chi2 = 0.066, DF = 1, P > 0.05).
Conclusions: Nurses were the health professionals who provided the largest proportion of reports of suspected ADRs and almost half of all reports during the Men C vaccination campaign. Their reports contained an equal proportion of serious suspected ADRs and the reports were documented as completely as those from GPs and hospital doctors.
Figures


Similar articles
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.Drug Saf. 2010 Sep 1;33(9):775-88. doi: 10.2165/11536510-000000000-00000. Drug Saf. 2010. PMID: 20701410
-
Reported paediatric adverse drug reactions in the UK 2000-2009.Br J Clin Pharmacol. 2012 Mar;73(3):437-46. doi: 10.1111/j.1365-2125.2011.04113.x. Br J Clin Pharmacol. 2012. PMID: 21988288 Free PMC article. Review.
-
Developing an adverse drug reaction reporting system at a teaching hospital.Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):408-11. doi: 10.1111/j.1742-7843.2008.00217.x. Epub 2008 Feb 29. Basic Clin Pharmacol Toxicol. 2008. PMID: 18312492
-
Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.Cent Afr J Med. 1998 Aug;44(8):190-5. Cent Afr J Med. 1998. PMID: 10101417
Cited by
-
Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance.Drug Saf. 2019 May;42(5):657-670. doi: 10.1007/s40264-018-0767-7. Drug Saf. 2019. PMID: 30649749
-
Non-medical prescribers and pharmacovigilance: participation, competence and future needs.Int J Clin Pharm. 2013 Apr;35(2):268-74. doi: 10.1007/s11096-012-9739-7. Epub 2013 Jan 1. Int J Clin Pharm. 2013. PMID: 23277419
-
UK veterinary professionals' perceptions and experiences of adverse drug reaction reporting.Vet Rec. 2022 Sep;191(6):e1796. doi: 10.1002/vetr.1796. Epub 2022 Jun 3. Vet Rec. 2022. PMID: 35665513 Free PMC article.
-
Incidence of adverse reactions to vaccines in a paediatric population.Clin Drug Investig. 2004;24(8):457-63. doi: 10.2165/00044011-200424080-00004. Clin Drug Investig. 2004. PMID: 17523706
-
Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.Drug Saf. 2010 May 1;33(5):409-16. doi: 10.2165/11319170-000000000-00000. Drug Saf. 2010. PMID: 20397740
References
-
- Rawlins MD. The Yellow Card Scheme: monitoring drug safety. Prescriber. 1996;7:101–104.
-
- Morrison-Griffiths S, Pirmohamed M. Specialist nurse reporting of adverse drug reactions. Professional Nurse. 2000;15:300–304. - PubMed
-
- Ada G, Isaacs D. Vaccination: the facts, the fears, the future. Melbourne: Mcpherson's Printing Group; 2000. Vaccine safety; pp. 86–105.
-
- Sacilotto K, Bagheri H, Lapeyre-Mestre M, Montastruc JL, Montastruc P. Adverse drug effect notifications by nurses and comparison with cases reported by physicians (French) Therapie. 1995;50:455–458. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous